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Abstract
Introduction: Recently, a novel protein, follicular dendritic cell secreted protein
(FDC-SP), has been identified in human periodontal ligament (PDL) tissue and
a biomolecular study suggested that the expression of FDC-SP might be
associated with the expression of the PDL phenotype. The purpose of this study
was to test the effect of FDC-SP on the proliferation and phenotype of PDL cells.
Material and methods: Periodontal ligament cells obtained following the 3rd
passage were exposed to various concentrations of FDC-SP . The cell proliferation
was monitored by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide(MTT) assay. Then, as a measure of osteogenic activity, the alkaline
phosphatase (ALP) activity was recorded after 4, 7, and 14 days using 
p-nitrophenylphosphate as a substrate. Finally, total RNA was extracted and 
RT-PCR was performed for gene analysis.
Results: The results indicated that PDL cells exposed to 50 ng/ml FDC-SP could
proliferate more rapidly. RT-PCR results showed that the mRNA expression of
epidermal growth factor receptor (EGFR) was obviously upregulated and the
mRNA expression of osteocalcin (OCN) and bone sialoprotein (BSP) were
downregulated in PDL cells exposed to FDC-SP . Moreover, two groups of PDL
cells exposed to FDC-SP showed a significant decrease of ALP activity during all
the culture days.
Conclusions: In sum, the findings observed in this study suggest that FDC-SP
in PDL cells could positively affect the proliferation and act as a fibroblastic
phenotype stabilizer by inhibiting their differentiation into mineralized tissue-
forming cells.
Key words: follicular dendritic cell secreted protein, periodontal ligament cells,
phenotype, proliferation.
Introduction
Millions of people are afflicted with periodontal diseases that cause
destruction of supporting structures of the teeth. The process can lead to
the loss of attachment and even contribute to atheroma formation and
the ensuing clinical complications [1]. The treatment of periodontal diseases
has long been a challenge in clinical periodontics. Despite considerable
research efforts in this area, regeneration of the periodontal ligament (PDL)
has still proved to be an elusive goal of periodontal therapy and remains
a subject of intense interest to dentists and dental scientists, with the
molecular and cellular bases of PDL tissue still poorly understood [2, 3].
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Therefore, an understanding of the intrinsic
functions of PDL tissue is required.
Periodontal ligament is an unmineralized
connective tissue that connects cementum and
alveolar bone and plays quite important roles such
as a shock absorber against the mastication impact
and receptor of biting forces [4, 5]. Periodontal
ligament cells are a heterogeneous population of
cells that can differentiate into fibroblasts,
cementoblasts, and osteoblasts [6, 7]. Moreover,
some studies have shown that about 3.9% of the
PDL cells termed PDLSCs could be induced to
differentiate into a Schwann cell phenotype [8].
Interestingly, despite the mechanical stress 
of mastication or orthodontic forces during
orthodontic movement, under physiological
conditions, the PDL always maintains its width
unmineralized. It has thus been speculated that
PDL cells possess regulatory mechanisms to
stabilize the fibroblastic phenotype and inhibit
mineralization [9].
In 2005, a novel protein, follicular dendritic cell
secreted protein (FDC-SP), was identified in human
PDL tissue, but not detected in the cultured PDL
cells [10]. Follicular dendritic cell secreted protein
is a small secretory protein having molecular
properties similar to statherin [11]. Statherin has
been suggested to play an important role in the
inhibition of spontaneous precipitation of calcium
salts in saliva. Therefore, it is tempting to speculate
that FDC-SP also prevents calcium precipitation in
PDL that is surrounded by mineralized tissues,
alveolar bone and cementum. Moreover, a bio  -
molecular study has suggested that the expression
of FDC-SP may be associated with the expression
of the PDL phenotype [10], and it is assumed that
FDC-SP may promote differentiation of periodontal
ligament cells towards a more fibroblastic
phenotype. However, the mechanism of FDC-SP in
expression of the PDL phenotype is still unclear.
Many investigations have been carried out to
demonstrate that PDL cells have the ability to
differentiate into osteoblast-like cells [12-14].
However, the precise functions of the PDL cells to
stabilize the fibroblastic phenotype and maintain
the PDL structural integrity remain largely unknown.
It is necessary to obtain a better understanding of
the phenotypic characteristics of PDL cells in order
to develop purposeful strategies to influence their
reparative capacities. 
The aim of this study was to elucidate the role
of FDC-SP in the proliferation and phenotype
change of PDL cells. First, PDL cells were derived
from human periodontal ligament by enzymatic
digestion and were exposed to various concen  -
trations of FDC-SP during the cell culture. After that,
the cell proliferation, alkaline phosphatase (ALP)
activity and mRNA expression of EGFR, OCN and
BSP genes were examined.
Material and methods
Cell culture
Human periodontal ligament cells were scraped
from the middle third of the roots of premolars
extracted from healthy human donors for
orthodontic reasons (donors’ age: 12 and 14 years
old). Informed consent had been obtained from
patients and parents, and an approved protocol of
the ethics committee of the Sichuan University had
been followed before tooth extraction. Briefly,
extracted teeth were washed twice with phosphate-
buffered saline (PBS) (5× penicillin and strepto  -
mycin, and 1× fungizone), then PDL tissue attached
to the mid-third of the root was removed with
a surgical scalpel and was teased into 1-2 mm3
fragments in tissue culture plates. PDL cells were
released from the scraped samples by a 30-min
enzymatic digestion (0.05% trypsin and 0.15%
collagenase; Sigma, St Louis, MO, USA). After
centrifugation, single cell suspensions were
prepared and cultured in a-MEM containing 10%
fetal bovine serum and 0.5% antibiotics, at 37°C 
in an atmosphere of 100% humidity and 5% CO2
until the cells were 90% confluent. Then the
cultures were washed twice with PBS, and the cells
were dissociated from the flasks with 0.25% trypsin
in 1 ml EDTA (GIBCO) for 5 min at 37°C. After
centrifugation, the cells were replated at 1 × 104
cells/cm2 and were further cultured as first-passage
cells, replenishing the culture medium as above.
Periodontal ligament cells at passage 3 were used
for the following experiment.
Preparation and application of follicular
dendritic cell secreted protein
A sample of 0.5 mg of the FDC-SP (ANASPEC,
San Jose, CA) was dissolved in 500 μl double-
distilled water. Then the FDC-SP solution was
diluted to 50 μg/ml with PBS and bovine serum
albumin (BSA). pH of resulting solution was
adjusted to 7.1.
Cell proliferation assay
Periodontal ligament cells obtained following the
3rd passage were seeded in a 96-well plate at
a density of 5 × 103 cells/well and cultured in
unsupplemented medium containing 10% FBS/ 
a-MEM (group A) or medium supplemented with 
10 ng/ml (group B), 50 ng/ml (group C), 100 ng/ml
(group D), 500 ng/ml (group E) FDC-SP respectively.
The cell proliferation was monitored after 1, 3, 5 and
7 d by using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenylArch Med Sci 2, April / 2011 237
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tetrazolium bromide (MTT; Sigma-Aldrich) assay.
Three parallel replicates were read for each sample.
Alkaline phosphatase activity
Periodontal ligament cells were seeded in 
a 24-well plate at a density of 5 × 104 cells/well and
exposed to varying concentrations of FDC-SP 
(0 ng/ml, 50 ng/ml, 100 ng/ml). The medium was
changed every 48 h. As a measure of osteogenic
activity, the ALP activity was recorded after 4, 7, 
and 14 days. Briefly, PDL cells were rinsed twice with
PBS after removal of the culture media, then 1 ml
of 10 mM Tris-HCl buffer, pH 8.5, was added. 
The cell layer was scraped off the plates and
homogenized by sonication three times on ice 
(10 s each time). ALP activity was assayed using 
p-nitrophenylphosphate as a substrate. The amount
of p-nitrophenol produced was measured spec  -
trophotometrically at a wave  length of 410 nm and
quantified against a standard curve. The rate of
increase in absorbance at this wavelength is directly
proportional to ALP activity in the sample. Alkaline
phosphatase levels were normalized to the total
protein content of cells at the end of the
experiment.
Total RNA extraction and RT-PCR analysis
Periodontal ligament cells were seeded in 
a 24-well plate at a density of 5 × 104 cells/well and
exposed to FDC-SP (50 ng/ml). And PDL cells
cultured in unsupplemented medium containing
10% FBS/ a-MEM served as a control. The medium
was changed every 48 h. The total cellular RNA from
each incubation was isolated using Trizol Reagent
(Invitrogen, Carlsbad, CA), according to the manu  -
facturer’s instructions. The RNA was then treated
with DNase and cDNA was synthesized using
PrimeScript Reverse Transcriptase (Takara Bio Inc.,
Shiga, Japan). The primer sets used for PCR were as
fol  lows: EGFR, 5’-GAGTAACAAGCTCACGCAGTTG-3’/
5’-GAGGACATAACCAGCCACCTC-3’ (product size: 
169 bp); osteocalcin, 5’-CTCACACTCCTCGCCCTATTG-3’/
5’-GCCTGGGTCTCTTCACTACCT-3’(product size: 142 bp);
BSP, 5’-AGGAGGAGGAAGAAGAGGAGACT-3’/
5’-CATAGCCCAGTGTTGTAGCAGA-3’ (product size: 114 bp)
and β-actin, 5’-GAATTCATGTTTGAGACCTTCAA-3’/
5’-CCGGATCCATCTCTTGCTCGAAGTCCA-3’ (product
size: 326 bp). Real-time polymerase chain reaction
(PCR) was performed using the software ABI PRISM
7300 SYSTEM SDS SOFTWARE. PCR amplification
reactions were carried out in a total volume 
of 20 μl in PCR master mix containing 10 μl of SYBR
Premix Ex Taq (Takara, Shiga, Japan), 0.4 μl of Rox
Reference Dye (Takara, Shiga, Japan), 0.8 μl of PCR
Forward Primer, 0.8 μl of PCR Reverse Primer and
2 μl of the reverse transcription product filled up to
20 μl with RNase-free H2O. Reactions for each gene
were performed in the following cycling conditions:
95°C for 10 s, and then 40 cycles of 95°C for 
5 s followed by 60°C for 31 s. Melting analysis and
agarose gel electrophoresis were performed to
confirm the specificity of the PCR products obtained
using each primer pair. The relative expression
levels of genes were analysed using the 2–ΔΔCt
method [15] by normalizing with β-actin house  -
keeping gene expression, and presented as fold
increase relative to the control group.
Western blot analysis
Treated cells were subjected to lysis buffer
(Keygen total protein extraction kit, Keygen Biotech.,
Nanjing, Jiangsu, China). The cytosolic fraction was
collected as the supernatant after centrifugation at
14,000 g at 4°C for 15 min and assayed quantitatively
with the BCA method. After boiling for 5 min, 
20-25 μl of the lysate (50 μg of protein) was applied
to SDS–12% PAGE at 120 V for 5 h, and the proteins
in the gel were transferred to a PVDF membrane
(Millipore Corp., Bedford, MA, USA). After blocking,
the membranes were probed with 1 : 1,000 dilutions
of the anti-EGFR, anti-OCN, and anti-BSP (Cell
Signaling Technology), followed by the addition of
horseradish peroxidase (HRP)-conjugated secondary
antibody (diluted 1 : 6,000) at 37°C for 1 h. Reactive
bands were visualized using an enhanced
chemiluminescence (ECL) kit (Amersham Corp.,
Arlington Heights, IL, USA). The density of the
bands was computer analysed by a densitometer
(Quantity One, Bio-Rad, USA).
Statistical analysis
All the experiments were performed in triplicate.
Each value was expressed as mean ± standard
deviation (SD). A one-way ANOVA was used to
compare the means of different data sets, and 
p values less than 0.05 were considered to be
significant.
Results
Cell proliferation assay
To examine the effects of concentration of 
FDC-SP on PDL cell proliferation, the cell numbers
in each culture were estimated by an MTT assay.
The results of the cell proliferation assay are
presented in Figure 1. At day 1, there was no
significant difference between the five groups. At
days 3, 5 and 7, there was a significantly greater
number of cells in group C containing 50 ng/ml
FDC-SP than other groups (p < 0.05). There was no
significant difference between group A and group B
(p > 0.05), and a conclusion was drawn that 
10 ng/ml FDC-SP may not be enough to promote
the PDL cell proliferation. Periodontal ligament cells238 Arch Med Sci 2, April / 2011
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cultured in 50 ng/ml FDC-SP showed the highest
cell proliferation activity, while addition of 100 ng/ml
or 500 ng/ml FDC-SP produced a decreased rate of
cell proliferation in comparison with 50 ng/ml 
FDC-SP . It is believed that a higher concentration of
FDC-SP than 50 ng/ml might have induced cellular
damage during culture. 
Alkaline phosphatase activity
To determine the effect of FDC-SP on the
osteogenic differentiation of PDL cells, ALP activity,
an early marker of odontoblast differentiation [16,
17], was measured. Figure 2 depicts the values of ALP
activity over protein concentration. The results
showed that addition of 50 ng/ml and 100 ng/ml of
FDC-SP significantly decreased the ALP activity in
PDL cells (p < 0.05). Higher levels of ALP activity were
always observed for cells harvested at day 7 com  -
pared to those harvested on days 4 and 14 (p < 0.05).
There was no significant difference of ALP activity
between two FDC-SP addition groups on days 
4 and 14. However, evident enhanced ALP activity
was observed in PDL cells cultured in 50 ng/ml FDC-
SP medium compared to those cultured in 100 ng/ml
FDC-SP medium on day 7 (p < 0.05).
Effects of FDC-SP on EGFR, OCN and BSP levels
in PDL cells
To determine the role of FDC-SP for PDL cell
phenotype, we examined the expression of mRNA
for EGFR, OCN, and BSP by RT-PCR. We noted that
expression of EGFR was upregulated in PDL cells
exposed to FDC-SP (50 ng/ml) in comparison with
control cells. Epidermal growth factor receptor
mRNA was improved over 2-fold on day 4 and 
4-fold on day 8 (Figure 3A). Moreover, lower
expression of osteogenic genes was observed in
PDL cells exposed to FDC-SP . For example, OCN,
a marker of terminal osteogenic differentiation,
demonstrated obvious decreased mRNA expression;
less than 0.4-fold on day 4, and less than 0.6-fold
on day 8 downregulation of this gene was 
noted (Figure 3B). And the BSP gene was also
downregulated during the entire observation period
(0.4- and 0.7-fold on day 4 and 8 respectively)
(Figure 3C).
Western blotting was performed to examine the
effect of FDC-SP on PDL cell phenotype. When cells
were treated with 50 ng/ml FDC-SP for 8 days, EGFR
protein was upregulated, and OCN and BSP protein
were downregulated (Figure 4). This is in agreement
with RT-PCR results on day 8.
Discussion
Once tissue destruction has occurred, one of the
major goals of periodontal therapy is to regenerate
the affected tissues to their original architecture
and function. To date, attempts to regenerate
periodontal tissues have focused almost exclusively
on regenerating lost alveolar bone [18-20]. However,
reconstruction of the periodontium is not just
a simple matter of regenerating one tissue but
involves at least three quite diverse and unique
tissues. The management of the PDL has always
been a challenge in clinical periodontics. There is
a growing requirement to regenerate PDL for the
treatment of periodontitis and implant dentistry
[21]. In response to this, cell-based therapies are
receiving increasing attention [22, 23].
Periodontal ligament cells consist of hetero  -
geneous cell populations that can differentiate into
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Figure 1. Results of an MTT assay showing relative
proliferation rates between different concentrations
of FDC-SP (group A: 0 ng/ml, group B: 10 ng/ml,
group C: 50 ng/ml, group D: 100 ng/ml, group E: 
500 ng/ml). Results represent the mean ± SD. The
intra-experiment coefficient of variation (CV) ranged
from 0.63% to 14.46%. The inter-experiment
coefficient of variation (CV) was 12.00%, 11.52%,
10.45% and 8.54% respectively
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Figure 2. Alkaline phosphatase activity in PDL cells
exposed to varying concentrations of FDC-SP 
(0 ng/ml, 50 ng/ml, 100 ng/ml) after 4, 7 and 14 days
of culture. Results represent the mean ± SD. The
intra-experiment CV ranged from 1.03% to 3.12%.
The inter-experiment CV was 12.77%, 20.66% and
12.00% respectively
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fibroblasts, cementoblasts, and osteoblasts [6, 7].
Evidence is accumulating that the phenotype of PDL
cells can be regulated by some cytokines [24-26].
In a clinical setting, it is essential to control the PDL
cells to be directed along fibroblastic or osteogenic
pathways for periodontal regeneration. One of the
most important findings of the present study was
that FDC-SP could act as a fibroblastic phenotype
stabilizer by inhibiting PDL cell differentiation into
mineralized tissue-forming cells through an 
EGFR pathway and maintain the PDL structural
integrity. The findings suggested that FDC-SP plays
an important role to induce the fibroblastic
differentiation of PDL cells and, therefore, might be
useful for controlling PDL cell differentiation and
mineralization for PDL regeneration.
It was demonstrated that PDL cells exposed to
50 ng/ml FDC-SP could proliferate more rapidly, and
there was no significant difference among other
groups. From these results, it would be a reasonable
assumption that FDC-SP may play a crucial role in
the proliferation of PDL cells, and the proliferation
may be regulated by the concentration of FDC-SP .
Some studies have implicated the EGF/EGFR
system in the process of phenotype regulation in
different cell populations [27-29] and both preo  -
steoblasts and prechondrocytes have numerous
EGFR in vivo. However, the number diminished
dramatically as their differentiation progressed. Fully
differentiated osteoblasts and chondrocytes did not
have any significant number of EGFR [30]. Moreover,
EGFR on PDL cells had an inhibitory effect on ALP
activity and functions as a negative regulator of
their differentiation into mineralized tissue forming
cells. Thus, the upregulation of EGFR on PDL
fibroblasts was considered to play an important role
in maintaining their phenotype, balancing the
population of fibroblasts in the PDL by inhibiting
their differentiation into mineralized tissue-forming
cells [31-34]. In this study, the mRNA expression of
EGFR was obviously upregulated in PDL cells
exposed to FDC-SP (over 2-fold on day 4 and 4-fold
on day 8). These findings may indicate that FDC-SP
enhances the PDL fibroblastic phenotype through
an EGFR pathway.
Alkaline phosphatase is a glycoprotein thought
to be involved in the formation of minerals in
calcifying tissues [35-37]. From the results, two
groups of PDL cells exposed to FDC-SP showed
a significant decrease of ALP activity during all the
culture days. These findings were consistent with
the previous speculation that FDC-SP may prevent
calcium precipitation in PDL according to amino acid
sequence analysis [11].
Osteocalcin is a major phosphorylated extra  -
cellular matrix protein in mineralised tissues,
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Figure 3. Expression of phenotype associated markers by PDL cells exposed to FDC-SP (50 ng/ml) and by control.
A – The level of EGFR mRNA expression. The intra-experiment CV was 3.44% on day 4 and 2.7% on day 8. The inter-
experiment CV was 51.46% on day 4 and 86.36% on day 8. B – The level of OCN mRNA expression. The intra-
experiment CV was 12.58% on day 4 and 14.21% on day 8. The inter-experiment CV was 80.33% on day 4 and 38.34%
on day 8. C – The level of BSP mRNA expression. The intra-experiment CV was 13.02% on day 4 and 8.54% on day 8.
The inter-experiment CV was 57.79% on day 4 and 23.04% on day 8. Results represent the mean ± SD 
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Figure 4. Expression of EGFR, OCN and BSP protein
after cells were treated with 50 ng/ml FDC-SP for 
8 days. Epidermal growth factor receptor protein was
upregulated, OCN and BSP protein were down  -
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whereas BSP, an early marker of bone formation,
is believed to be involved in the proliferation and
migration of osteogenic cell populations. RT-PCR
results showed that the mRNA expression of OCN
and BSP were downregulated in PDL cells exposed
to FDC-SP, which was in accordance with the results
of ALP observations. More importantly, the decrease
of ALP, OCN and BSP activation was accompanied
by an increase of EGFR content. These observations
suggested the novel role of FDC-SP to be a negative
regulator of PDL cell differentiation into osteoblastic
cells and maintain the PDL fibroblastic phenotype,
which may be through an EGFR pathway. 
In conclusion, the findings observed in this study
suggest that FDC-SP in PDL cells could positively
affect their proliferation and act as a fibroblastic
phenotype stabilizer by inhibiting their differen  -
tiation into mineralized tissue-forming cells through
an EGFR pathway. These findings, together with the
results reported previously [10], provide information
to support the hypothesis that FDC-SP may be
a potential factor associated with the expression
of the PDL phenotype, and maintaining the 
PDL structural integrity that is surrounded by
mineralized tissues, alveolar bone and cementum.
Further studies are needed to establish signal
transduction mechanisms and second messenger
pathways operating in PDL cells as a result of 
FDC-SP interaction.
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